Dexmethylphenidate
- Generic Name
- Dexmethylphenidate
- Brand Names
- Azstarys, Focalin
- Drug Type
- Small Molecule
- Chemical Formula
- C14H19NO2
- CAS Number
- 40431-64-9
- Unique Ingredient Identifier
- M32RH9MFGP
- Background
Dexmethylphenidate is the dextrorotary form of methylphenidate introduced in 2002. It is a norepinephrine-dopamine reuptake inhibitor (NDRI) and thus a psychostimulant. It is used for treatment of Attention Deficit Hyperactivity Disorder (ADHD). The d-isomer is thought to have greater effect with fewer side effects than the l-isomer or the racemic mixture.
- Indication
Dexmethylphenidate is used as a treatment for ADHD, ideally in conjunction with psychological, educational, behavioral or other forms of treatment.
- Associated Conditions
- Attention Deficit Hyperactivity Disorder (ADHD)
- Associated Therapies
- -
Fed-Fast Crossover Study to Assess the Effect of Food With CTx-1301 in Healthy Subjects
- Conditions
- Interventions
- First Posted Date
- 2020-06-26
- Last Posted Date
- 2022-10-20
- Lead Sponsor
- Cingulate Therapeutics
- Target Recruit Count
- 27
- Registration Number
- NCT04449250
- Locations
- 🇺🇸
Dr. Vince Clinical Research, Overland Park, Kansas, United States
Sleep and Tolerability Study: Comparing the Effects of Adderall XR and Focalin XR
- Conditions
- Interventions
- First Posted Date
- 2006-10-26
- Last Posted Date
- 2017-04-19
- Lead Sponsor
- Seattle Children's Hospital
- Target Recruit Count
- 77
- Registration Number
- NCT00393042
- Locations
- 🇺🇸
Northbrook HALP Clinic/ADHD Research Center, Northbrook, Illinois, United States
🇺🇸University of Illinois at Chicago, Chicago, Illinois, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.